ID: MRFR/MED/1678-HCR | February 2021 | Region: Global | 80 pages
Market Synopsis of Global Coronary Artery Bypass Graft Market:
Coronary artery bypass grafting (CABG) is a type of bypass surgery that is used to create a new path for blood to flow to the heart. This is used for patients who have severe coronary heart disease. CABG is the most common type of open heart surgery in the United States. Deskbound lifestyle, anxiety, stress and high consumption of junk food are key reasons that causes cardiovascular diseases in individuals around the globe. The market for coronary artery bypass graft is growing rapidly. The credit of this high growth can be given to increasing number of cases of cardiovascular disease which is the result of changing lifestyle along with it increase in patient’s awareness about this disease, related surgeries and therapies.
The global market for coronary artery bypass graft is expected to reach around USD 116 million by the end of the forecast period and is expected to grow at the CAGR of ~6.0%.
Study Objectives Global Coronary Artery Bypass Graft Market:
Global Coronary Artery Bypass Graft Market, by Type, 2015 (%):
Key Players for Global Coronary Artery Bypass Graft Market:
Some of the key players in this market are: Hancock Jaffe Laboratories, Inc., Terumo Cardiovascular Systems Corporation, VasoPrep Surgical, Dextera Surgical Inc., Neograft Inc., NOVADAQ Technologies Inc., MAQUET Holding B.V. & Co. KG., Genesee BioMedical, Sorin Group, Edwards Lifesciences Corporation and others.
Global coronary artery bypass graft market has been segmented on the basis of type which comprises of off-pump, on-pump, minimally invasive direct CABG, endoscopic vein harvesting and others. On the basis of procedure; the market is segmented into single CABG surgery, double CABG surgery, triple CABG surgery, quadruple CABG surgery and others. On the basis of end users the market is segmented into hospitals, cardiology clinics, research institutes and others.
Regional Analysis of Global Coronary Artery Bypass Graft Market:
Globally North America is the largest market for coronary artery bypass graft. The North American market for coronary artery bypass graft is growing with the CAGR of ~6.4% during the forecast period of 2016-2022. Europe is the second-largest market for coronary artery bypass graft. Asia pacific region is expected to be fastest growing region in coronary artery bypass graft market.
The report about Global Coronary Artery Bypass Graft Market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of different markets segments and regions.
Frequently Asked Questions (FAQ) :
coronary artery bypass graft market is projected grow at approximately 6% CAGR during the assessment period (2016-2022).
The valuation of the global coronary artery bypass graft market is estimated to increase to USD 116 MN by the end of 2022.
Increase in the number of cardiovascular disease cases, growing awareness about the disease and availability of treatments, strong encouragement from government, and increasing medical expenditure are the major tailwinds pushing the growth of the global coronary artery bypass graft market.
North America holds the largest share in the global coronary artery bypass graft market, followed by Europe and the Asia Pacific, respectively.
Terumo Cardiovascular Systems Corporation, Hancock Jaffe Laboratories, Inc., VasoPrep Surgical, Neograft Inc., Dextera Surgical Inc., NOVADAQ Technologies Inc., Genesee BioMedical, MAQUET Holding B.V. & Co. KG., Sorin Group, and Edwards Lifesciences Corporation, are some of the major players operating in the coronary artery bypass graft market.
Table of Contents
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Coronary Artery Bypass Graft Market, by Type
5.1.3 Minimally Invasive Direct CABG
5.1.4 Endoscopic Vein Harvesting
6 Global Coronary Artery Bypass Graft Market, by Procedure
6.1.1 Single CABG Surgery
6.1.2 Double CABG Surgery
6.1.3 Triple CABG Surgery
6.1.4 Quadruple CABG Surgery
7 Global Coronary Artery Bypass Graft Market, by End User
7.1.3 Cardiology Clinics
7.1.4 Research Institutes
8 Global Coronary Artery Bypass Graft Market, by Regions
126.96.36.199 North America
188.8.131.52 South America
184.108.40.206 Rest of Europe
8.1.3 Asia Pacific
220.127.116.11 Republic of Korea
18.104.22.168 Rest of Asia Pacific
8.1.4 Middle East & Africa
9 Company Landscape
9.1.1 Mergers Acquisitions
9.1.3 Release/New Product Launches
9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
10.1 Dextera Surgical Inc.
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Edwards Lifesciences Corporation
10.2.2 Product/Business Segment Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Genesee BioMedical
10.3.2 Product/Business Segment Overview
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 Hancock Jaffe Laboratories, Inc.
10.4.2 Product/Business Segment Overview
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.5 MAQUET Holding B.V. & Co. KG.
10.5.2 Product/Business Segment Overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Neograft Inc.
10.6.2 Product/Business Segment Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 NOVADAQ Technologies Inc.
10.7.2 Product/Business Segment Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Sorin Group
10.8.2 Product/Business Segment Overview
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Terumo Cardiovascular Systems Corporation
10.9.2 Product/Business Segment Overview
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 VasoPrep Surgical
10.10.2 Product/Business Segment Overview
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 Scion Medical Technologies, LLC.
List of Tables
TABLE 1 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, 2020-2027 (USD MILLION)
TABLE 2 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY PROCEDURE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY REGION, 2020-2027 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY TYPE
FIGURE 4 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY PROCEDURE
FIGURE 5 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY END USER
FIGURE 6 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET, BY REGION
FIGURE 7 GLOBAL CORONARY ARTERY BYPASS GRAFT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)